- PROFESSOR Radiology
- PROFESSOR Medicine
MD, Universite D' Alger
Universite D' Alger
Residency, Diagnostic Imaging
Paris VI University (France)
University of California - San Francisco
- Bachir Taouli, MD, is Associate Professor of Radiology and Medicine in the Body Imaging Section (Department of Radiology) at The Mount Sinai Medical Center. After completing medical school and Radiology Residency in Paris VI University (France) in 2000, he joined UCSF Department of Radiology for a research fellowship and clinical training. He then joined the NYU Department of Radiology where he worked for 6 years and where he developed clinical applications of advanced MRI techniques applied to liver, kidney and prostate diseases, including diffusion and perfusion imaging and spectroscopy. Recently, he joined Mount Sinai Medical Center where he is currently the director of Body MRI in the Department of Radiology. With state of art equipment available at Mount Sinai, advanced MRI techniques will be offered as part of routine studies or in research protocols. These methods are useful for better disease detection and characterization, and for assessment of response to therapy. Dr Taouli is a member of the Radiological Society of North America, International Society of Magnetic Resonance in Medicine, American Roentgen Ray Society, Society of Gastrointestinal Radiologists, European Society of Radiology, American Association for the Study of Liver Diseases, Society of Uroradiology, European Society of Magnetic Resonance in Medicine and Biology, and European Society of Gastrointestinal and Abdominal Radiology. He is an Associate editor for the American Journal of Roentgenology. Dr Taouli is a member of the Annual Meeting Program Committee of the International Society of Magnetic Resonance in Medicine, and Radiological Society of North America Gastrointestinal Radiology Subcommittee. Dr. Taouli authored or co-authored over 60 published peer-reviewed manuscripts and book chapters primarily on body MRI. Dr. Taouli has lectured throughout the world on advanced body MRI techniques.
Click here to view Dr. Taouli's publications
2011 - 2012
10th International Symposium on High Field MRI
2008 - 2009
Society of Uroradiology
2007 - 2009
Radiological Society of North America
2004 - 2005
Society of Gastrointestinal Radiologists
Assessment of prostate cancer with MRIMRI is the primary modality used for prostate cancer detection and staging. One of Dr Taouli's research interests is the use of multiparametric MRI to better detect and stage prostate cancer, and assess and predict response to radiation therapy.
Non invasive detection of liver fibrosis and cirrhosis with MRIMRI is a versatile technique, with no radiation exposure, and the possibility of performing multiparametric imaging. One of the interesting applications of MRI is the non invasive detection of liver damage caused by hepatitis and other insults, usually assessed with liver biopsy. Dr Taouli's experience using diffusion and perfusion MRI showed potential usefulness for detection of liver fibrosis and cirrhosis. MR elastography is also an emerging technique that will soon be offered routinely to patients with liver disease at Mount Sinai.
Assessment of liver cancer with advanced MRI methodsPrimary liver cancer (hepatocellular carcinoma: HCC) can be treated aggressively when diagnosed early, using for example hepatic resection of transplantation. Imaging plays a pivotal role in the detection of hepatocellular carcinoma. MRI is especially attractive as it is radiation free and can be easily repeated in patients with liver disease on a regular basis. One of Dr Taouli's research interests is to characterize liver tumors in terms of aggressiveness, angiogenesis and oxygen delivery through the use of advanced MRI methods.
Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?. AJR. American journal of roentgenology 2011 May; 196(5).
Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE, Taouli B. Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Investigative radiology 2011 May; 46(5).
Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. Journal of magnetic resonance imaging : JMRI 2011 Jan; 33(1).
Do RK, Chandarana H, Chandanara H, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR. American journal of roentgenology 2010 Sep; 195(3).
Merkle EM, Szklaruk J, Taouli B, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B. Imaging techniques in the diagnosis of hepatocellular carcinoma and metastatic carcinoma as a result of colon cancer. Gastroenterology & hepatology 2010 Aug; 6(8).
Marien T, Taouli B, Telegrafi S, Babb J, Lepor H. Optimizing the detection of subclinical inguinal hernias in men undergoing open radical retropubic prostatectomy. BJU international 2010 Nov; 106(10).
Lim RP, Tuvia K, Hajdu CH, Losada M, Gupta R, Parikh T, Babb JS, Taouli B. Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging. AJR. American journal of roentgenology 2010 May; 194(5).
Rosenkrantz AB, Kopec M, Kong X, Melamed J, Dakwar G, Babb JS, Taouli B, Taouli B. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. Journal of magnetic resonance imaging : JMRI 2010 Jun; 31(6).
Rosenkrantz AB, Neil J, Kong X, Melamed J, Babb JS, Taneja S, Taouli B. Prostate Cancer: Comparison of 3D T2-weighted sequence (SPACE) with conventional 2D T2-weighted imaging for Image Quality and Tumor Detection. AJR Am J Roentgenol 2010; In press.
Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B, Taouli B. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?. AJR. American journal of roentgenology 2011 May; 196(5).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Taouli during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Bayer HealthCare Pharmaceuticals / Onyx Pharmaceuticals Partnership; Siemens
Scientific Advisory Board:
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
Hess CSM Building Floor TMII 1st Floor Room 107
1470 Madison Avenue
New York, NY 10029
1176 Fifth Avenue, MC Level
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm